Announcement, From Bench to Fireside 02.22.24 Share on Twitter Share on Facebook Share on LinkedIn From Synthetic Biology to Emerging Technologies with Justin Eyquem, PhD In this episode, Justin Eyquem, PhD, Parker Senior Fellow and PICI Member Researcher at the University of California, San Francisco, talks about his visionary work pioneering CAR-T cell therapies and synthetic biology with PICI Chief Scientific Officer John Connolly, PhD. Listen as Justin provides an inside look at the CAR-T revolution, from next-generation therapies to cutting-edge advancements like in vivo delivery and AI-powered design. Hear him discuss his journey from bioengineering student to gene-editing innovator with support from PICI’s collaborative network of experts and resources. Get ready to go from bench to fireside with Justin Eyquem, PhD. Listen on Spotify Related Announcement, Press Release Parker Institute Commits Additional $125M for Audacious Mission to Cure Cancer Announcement, Press Release The Parker Institute for Cancer Immunotherapy Awards More Than $1 Million to Four Early Career Investigators Announcement Behind the Breakthrough: An Interview with Carl June, the Father of CAR T-Cell Therapy
Announcement, Press Release Parker Institute Commits Additional $125M for Audacious Mission to Cure Cancer
Announcement, Press Release The Parker Institute for Cancer Immunotherapy Awards More Than $1 Million to Four Early Career Investigators